Literature DB >> 32567328

Study of the Risk and Preventive Factors for Progress of Mild Cognitive Impairment to Dementia.

Chengping Hu1, Ling Wang1, Yi Guo2, Zhicheng Cao2, Ying Lu2, Hongyun Qin2.   

Abstract

OBJECTIVE: To evaluate the risk factors for progress of mild cognitive impairment to dementia.
METHODS: This study was based on the epidemiological survey in 2011 (No. PKJ2010-Y26) and contained 441 MCI individuals. Cognitive function was measured by the Mini-Mental Status Examination, clinical dementia rating, and montreal cognitive assessment. The association between demographic characteristics and MCI outcomes were evaluated using single-and multifactor ordered logistic regression analysis models.
RESULTS: Of the 441 MCI, 77 progressed to dementia (MCIp: 17.5%, 95% CI: 14.4%-21.6%), 356 remained stable (MCIs: 80.7%, 95% CI: 77.0%-88.4%), and 8 reverted to normal cognition (MCIr: 1.8%, 95% CI: 0.6%-3.0%) at follow-up in 2017. Univariate ordinal regression analysis showed that diabetes (P = .052), marriage (P = .028), worker (P = .069), and manager (P = .075) may be the risk factor for the status of MCI. Multiple ordinal regression results showed that diabetes (P = .049) and marriage (P = .04) significantly affected the cognitive function changes in the MCI patients.
CONCLUSION: Nondiabetics and being married may prevent the progression from MCI to dementia.

Entities:  

Keywords:  dementia; diabetes; education; mild cognitive impairment; ordered logistic regression analysis; past occupation

Mesh:

Year:  2020        PMID: 32567328     DOI: 10.1177/1533317520925324

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  2 in total

1.  Association between tooth loss rate and risk of mild cognitive impairment in older adults: a population-based longitudinal study.

Authors:  Shuyu Xu; Xi Huang; Yin Gong; Jiangwei Sun
Journal:  Aging (Albany NY)       Date:  2021-09-07       Impact factor: 5.682

2.  Speed of Processing (SoP) Training Plus α-tACS in People With Mild Cognitive Impairment: A Double Blind, Parallel, Placebo Controlled Trial Study Protocol.

Authors:  Jorge Leite; Óscar F Gonçalves; Sandra Carvalho
Journal:  Front Aging Neurosci       Date:  2022-07-14       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.